Focus on success: using a probabilistic approach to achieve an optimal balance of compound properties in drug discovery.
about
The challenges of making decisions using uncertain data.Treponema pallidum putative novel drug target identification and validation: rethinking syphilis therapeutics with plant-derived terpenoids.3D pharmacophoric similarity improves multi adverse drug event identification in pharmacovigilance.Prioritizing Hits with Appropriate Trade-Offs Between HIV-1 Reverse Transcriptase Inhibitory Efficacy and MT4 Blood Cells Toxicity Through Desirability-Based Multiobjective Optimization and Ranking.In silico prediction of ADMET properties: how far have we come?A structural feature-based computational approach for toxicology predictions.Advances in multiparameter optimization methods for de novo drug design.Lipoxygenase directed anti-inflammatory and anti-cancerous secondary metabolites: ADMET-based screening, molecular docking and dynamics simulation.DNA topoisomerase-directed anticancerous alkaloids: ADMET-based screening, molecular docking, and dynamics simulation.The forgotten or underestimated relevance of biopharmaceutical-based assessments for the oral absorption studies of oxime reactivators.Molecular Docking Analysis of Selected Clinacanthus nutans Constituents as Xanthine Oxidase, Nitric Oxide Synthase, Human Neutrophil Elastase, Matrix Metalloproteinase 2, Matrix Metalloproteinase 9 and Squalene Synthase InhibitorsFrom flamingo dance to (desirable) drug discovery: a nature-inspired approach.QSAR with experimental and predictive distributions: an information theoretic approach for assessing model quality.Time dependent analysis of assay comparability: a novel approach to understand intra- and inter-site variability over time.The risks of subconscious biases in drug-discovery decision making.USING CHEMOINFORMATICS TOOLS TO ANALYZE CHEMICAL ARRAYS IN LEAD OPTIMIZATION
P2860
Q30977737-A951EA92-36A9-4476-B72B-41F1869317A0Q35067843-1E31B602-9765-4EB1-B72C-2DB92DDB08DCQ35153278-5E9BB259-A2AD-400A-ACB3-447B79C623BCQ36087023-825EEDB5-E24A-4FB3-A255-B94189A4F506Q36960530-2806A02A-27AB-47CE-86C1-809F4DE7CE45Q37674610-C13AA065-BBFB-4C16-99B8-82BE11DC7013Q38209075-227FCF06-E876-44E6-A67E-ED901A90CDA2Q38382387-7593F4CB-A78B-46CB-9D20-6D590C2D3D5AQ38392591-BDA128D3-2572-4BBB-B402-97FDE0756979Q38825239-D65FCFD9-CE1D-453A-8389-121F6F988F03Q39005095-BFA48718-8FDC-4323-811E-FC331BBE65BCQ39380258-4EE14371-4D71-459F-B1E8-23C9E2A7372AQ40218957-45FEED76-0C8F-4262-9B12-CD8AD4E6A1B2Q41387262-C7300A37-612B-463F-9B42-F73ACF2F092EQ51703111-212C428E-9A8B-4DA9-858F-9E0C75BB44FEQ56915997-A4A75D18-BD52-4275-A3FF-49E2B22C797A
P2860
Focus on success: using a probabilistic approach to achieve an optimal balance of compound properties in drug discovery.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Focus on success: using a prob ...... properties in drug discovery.
@ast
Focus on success: using a prob ...... properties in drug discovery.
@en
type
label
Focus on success: using a prob ...... properties in drug discovery.
@ast
Focus on success: using a prob ...... properties in drug discovery.
@en
prefLabel
Focus on success: using a prob ...... properties in drug discovery.
@ast
Focus on success: using a prob ...... properties in drug discovery.
@en
P2093
P2860
P356
P1476
Focus on success: using a prob ...... properties in drug discovery.
@en
P2093
Alan P Beresford
Dan Hawksley
Joelle Mr Gola
Matt D Segall
Mike H Tarbit
P2860
P304
P356
10.1517/17425255.2.2.325
P407
P577
2006-04-01T00:00:00Z